Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
about
Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric DisordersThe endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.The endocannabinoid system in anxiety, fear memory and habituation.Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cellsEndocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm.Anxiogenic-like effects of chronic cannabidiol administration in rats.Neuroanatomical circuitry mediating the sensory impact of nicotine in the central nervous systemThe psychiatric side-effects of rimonabant.Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in ratsInhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness.Neuroanatomical substrates involved in cannabinoid modulation of defensive responses.Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmittersPeriaqueductal gray c-Fos expression varies relative to the method of conditioned taste aversion extinction employed.Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.Cannabinoid Modulation of the Stressed Hippocampus.New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents.
P2860
Q26767489-F8493E28-A277-410D-9609-5423D852597FQ30455787-9EC180CF-D80F-4487-8E48-DBCB7F1068B7Q30471032-34B1EAA2-F93F-4CA2-A8E5-244B94C26B84Q30471073-6711E16A-C32A-4B43-A863-F51CDDF0746AQ30473707-87F92D63-6458-4810-8B9C-D0963324CD8FQ33620621-6F57D528-C2DC-473D-BCCE-EBEAD11BB5CCQ34028554-3D3E2539-859A-429F-A965-50E3E53406A9Q34232627-14A8E7B8-7F02-4AD6-A7B3-35E528793C12Q34734457-A1DA75CA-D574-4689-914B-669BE554C21FQ34990771-DD7DC811-36AA-4D8D-BA2B-E5967A086DE5Q35119719-C836FF00-0757-4729-BF48-544636A5063BQ35130530-037E0A69-38A3-414B-B2CF-21C0867BB079Q35841051-E788F369-7475-4D44-BF1E-58F87AF978FFQ37880502-9F078208-8A1D-44C8-86D6-F9C2145A16E3Q37990798-3084165F-A574-455F-A5D7-47B53DC38C04Q38925087-7C8DE894-371B-4428-9B1C-06004F927C78Q38974387-40B0B0EB-20D5-45F5-9251-3833DE794BFBQ39904600-CE29B6D9-0630-41D0-B376-5A11FE7ACA3FQ44342705-3115F42C-D649-4D7E-A010-06F849455D57Q47661316-DFB53DC8-0B27-45D4-9750-4BB5385C7719Q47837489-F19BF1FC-CE55-4850-9914-175329B0AAC5
P2860
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
@en
type
label
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
@en
prefLabel
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
@en
P2093
P2860
P356
P1433
P1476
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
@en
P2093
A C Campos
A L Terzian
D C Aguiar
F A Moreira
F S Guimarães
L B Resstel
P2860
P304
P356
10.1155/2009/625469
P577
2008-12-02T00:00:00Z